The Enterprise Value as of January 2026 (TTM) for RayzeBio, Inc. Common Stock (RYZB) is 3.63B

According to RayzeBio, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 3.63B. This represents a change of 2.27% compared to the average of 153.32M of the last 4 quarters.

RayzeBio, Inc. Common Stock (RYZB) Historical Enterprise Value (quarterly & annually)

How has RYZB Enterprise Value performed in the past?

The mean historical Enterprise Value of RayzeBio, Inc. Common Stock over the last ten years is 857.71M. The current 3.63B Enterprise Value has changed 42.24% with respect to the historical average. Over the past ten years (40 quarters), RYZB's Enterprise Value was at its highest in in the December 2022 quarter at 536.85M. The Enterprise Value was at its lowest in in the June 2023 quarter at -23200000.00.

RayzeBio, Inc. Common Stock (RYZB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RayzeBio, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RayzeBio, Inc. Common Stock (RYZB) Average Enterprise Value

How has RYZB Enterprise Value performed in the past?

The current Enterprise Value of RayzeBio, Inc. Common Stock (RYZB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

RayzeBio, Inc. Common Stock (RYZB) Enterprise Value vs. Peers

How is RYZB’s Enterprise Value compared to its peers?

RayzeBio, Inc. Common Stock’s Enterprise Value is less than CymaBay Therapeutics, Inc. (3.64B), greater than SpringWorks Therapeutics, Inc. (3.48B), less than Mirati Therapeutics, Inc. (3.93B), greater than Opthea Limited (597.99M), less than Alpine Immune Sciences, Inc. (4.42B), greater than Morphic Holding, Inc. (2.81B), greater than MorphoSys AG (2.88B), greater than Chinook Therapeutics, Inc. (2.63B), greater than Myovant Sciences Ltd. (2.59B), less than 1Life Healthcare, Inc. (3.83B),

Build a custom stock screener for RayzeBio, Inc. Common Stock (RYZB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RayzeBio, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RayzeBio, Inc. Common Stock (RYZB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RayzeBio, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.